depression and semaglutide Weight loss drugs linked to lower likelihood of anxiety diagnoses: Study The risk of depression, anxiety,

Welcome to the ECHAR network

Lead author Professor Sunil Badve, Professorial Fellow at The George Institute for Global Health and UNSW Sydney said the study expanded current knowledge about this class of drugs in key areas, including benefits in people with CKD, and in people with and without diabetes

When injections may be better You want treatments backed by strong clinical trial data

Semaglutide is typically administered as a subcutaneous injection, meaning its injected under the skin

Currently, weight loss or weight-neutral antidiabetic drugs mainly include metformin, alpha-glucosidase inhibitors, GLP-1 receptor agonists (GLP-1RA), DPP-4 inhibitors, SGLT-2 inhibitors (SGLT-2i), and insulin analogs